Cairns Health
Andrew Ritter is an experienced executive with a strong background in healthcare and biotechnology. Currently serving as the Chief Executive Officer of Cairns Health since September 2023, Andrew is leading the development of Luna, a digital care companion platform for senior living and home care. Previously held positions include Chief Executive Officer of Docbot, where Andrew advanced AI technology for diagnosing gastrointestinal diseases, and President and Chief Executive Officer of Ritter Pharmaceuticals, a company known for developing the first potential FDA-approved treatment for lactose intolerance. Additionally, Andrew served on the board of Myosin Therapeutics, focusing on innovative therapies targeting cellular motor proteins. Andrew's educational background includes an MBA in Finance from The Wharton School and a BA in Political Science from the University of Southern California.
Cairns Health
Cairns Health is creating a fundamentally better healthcare experience for people with chronic health conditions and those that care for them. We make healthcare more accessible by simplifying complex care plans, connecting care teams and meeting patients where they live. Through our conversational AI, patients use their voice to interact with our digital care companion, who proactively gives medication reminders, symptom checks, behavioral nudges and even engages in friendly conversation to ease loneliness. Cairns uses radar to put the patient in context and passively monitors their activities, including: heart rate, breathing rate and sleep stages, all without a wearable. The result is informed and timely intervention that drives improved clinical outcomes, reduced care delivery costs and a more satisfactory healthcare experience for all.